Monday, 16 November 2026Follow on ๐•

Deal tracker

Biopharma acquisitions, licensing deals and partnerships, updated automatically every day from company announcements and filings. Values are headline figures in US dollars, including milestone payments where disclosed.

Deals in 2026
12
Disclosed value
$45bn
Largest deal
$19bn
AnnouncedBuyer or partnerTarget or assetTypeValueStatusSource
16 Nov 2026 Novartis OBI PharmaNext-generation ADC platform Licensing $2bn$30mn upfront Announced Source โ†—
30 Jan 2026 AstraZeneca CSPC Pharmaceutical GroupEight weight-management programmes Licensing $19bn$1.2bn upfront Announced Source โ†—